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MicroRNAs (miRNAs) have recently been found to be critical regulators of metabolic homeostasis. A study in
Nature by Trajkovski et al. (2011) shows that the highly related miRNAs miR-103 and miR-107 modulate
insulin sensitivity and glucose homeostasis in obese mice. These miRNAs might represent therapeutic
targets to ameliorate obesity-associated insulin resistance.Obesity-related insulin resistance is
frequently associated with other meta-
bolic abnormalities, such as aberrant
cholesterol/lipid homeostasis and nonal-
coholic fatty liver disease (NAFLD), and
represents a key component of metabolic
syndrome (Moller and Kaufman, 2005).
While the underlying mechanisms contri-
buting to insulin resistance and metabolic
dysregulation remain to be fully eluci-
dated, recent studies have uncovered
a key role for small (20–25 nucleotides)
noncoding microRNAs (miRNAs) as novel
regulators of metabolism (Kru¨tzfeldt and
Stoffel, 2006). Indeed, several miRNAs,
including miR-122 and miR-33a/b, have
been shown to control cholesterol/lipid
homeostasis and may represent potential
therapeutic targets to treat cardiometa-
bolic disorders (Najafi-Shoushtari, 2011).
MiRNAs may also be linked to metabolic
changes occurring in insulin resistance
and diabetes mellitus (Guay et al., 2011;
Jordan et al., 2011). In their recent study
inNature, Stoffel and colleagues (Trajkov-
ski et al., 2011) make an important mech-
anistic advance by demonstrating that
the miR-103/107 miRNAs are elevated in
livers of obese mice and represent potent
regulators of insulin signaling and glucose
homeostasis (Figure 1A).
Insulin resistance has been linked to
increased hepatic lipogenesis and steato-
sis associated with obesity (Leavens
and Birnbaum, 2011). Moreover, intricate
signaling crosstalk and lipid/metabolite
trafficking between liver and adipose
tissues play important roles in controlling
metabolic and glucose homeostasis to
accommodate organism energy needs.
To determine whether miRNAs might be
dysregulated in obesity-associated fatty
liver diseases, Trajkovski et al. performed
DNA microarray analysis of miRNA ex-pression in livers from leptin-deficient
(ob/ob) and diet-induced-obese (DIO)
mice. While a number of miRNAs were
shown to be up- or downregulated as
compared to wild-type mice on regular
chow, the authors chose to focus on the
highly related miR-103/107 found to be
overexpressed in the livers of obese
mice. Expression of miR-103/107 was
also modestly increased in livers of
humans with NAFLD and nonalcoholic
steatohepatitis (NASH), and elevated
miR-103/107 levels correlated with the
subjects’ homeostatic model assessment
(HOMA) status, potentially linking these
miRNAswith insulin resistance in humans.
To test whether miR-103/107 are
indeed associated with regulation of
insulin sensitivity, Trajkovski et al. initially
overexpressed miR-107 in mouse liver
by adenovirus injection, which resulted
in elevated fasting glucose and insulin
levels, impaired glucose tolerance and
insulin sensitivity, and increased hepatic
glucose production. Conversely, injection
of antisense oligonucleotides (antago-
mirs) into obese mice silenced miR-103/
107 expression in liver and fat and
improved multiple aspects of aberrant
glucose homeostasis and insulin resis-
tance that are associated with obesity.
Because of the complex metabolic inter-
play of liver and adipose tissues, the
authors examined the possibility that
adipose-selective functions of miR-103/
107 might also contribute to the regula-
tion of insulin/glucose responsiveness.
Indeed, they found that manipulation of
miR-103/107 levels in adipose tissue
resulted in altered glucose homeostasis
and insulin sensitivity. A number of
studies have shown that insulin sensitivity
is associated with the size of adipocytes
(the smaller, the better). Accordingly, anti-Cell Metabolism 1sense silencing of miR-103/107 in obese
(DIO and ob/ob) mice caused a decrease
in fat pad size and smaller adipocytes,
accompanied by increased insulin-stimu-
lated glucose uptake in isolated adipo-
cytes. In addition, antagomir injection
increased the expression of fatty acid
b-oxidation genes in adipocytes of
obese mice, which was correlated with
increased metabolic output, as evi-
denced by elevated O2 consumption and
increased body temperature, without
changes in food intake. While the func-
tional consequences of elevated miR-
103/107 in the livers of these mice are
less clear, the data suggest that in leptin-
deficient and DIO mice, the adipose-
related effects of these miRNAs are
an important regulator of homeostatic
insulin/glucose levels. Together, these
results suggest that miR-103/107 could
represent important regulators of insulin
sensitivity and glucose homeostasis in
the context of obesity.
How do miR-103/107 control insulin/
glucose homeostasis? miRNAs typically
regulate the translation and/or levels of
hundreds of mRNAs, chiefly through their
30 UTRs. To determine which targets
might be involved in mediating the effects
of miR-103/107 on glucose homeostasis/
insulin sensitivity, the authors over-
expressed miR-107 in liver, followed by
DNA microarray analysis. This study
uncovered caveolin-1 (Cav1), a protein
known to physically and functionally
interact with the insulin-signaling pathway
(Yamamoto et al., 1998), as a potential
target of miR-107. Cav1 is central to the
generation and maintenance of plasma
membrane domains termed caveolae
(Parton and Simons, 2007). These choles-
terol/sphingolipid-rich ‘‘little caves’’ or
invaginations in the plasma membrane4, August 3, 2011 ª2011 Elsevier Inc. 149
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Figure 1. Model of miR-103/107 Regulation of Insulin Sensitivity and Glucose Homeostasis
(A) miR-103/107 were found to be elevated in liver of obese mice. Data suggest that increased expression of miR-103/107 in liver and adipose tissues could
contribute to insulin resistance and glucose intolerance.
(B) Caveolin-1 (Cav1) was shown to be a direct target of miR-103/107 in adipocytes, and downregulation of Cav1 expression by miR-103/107 resulted in
decreased insulin (Ins) signaling through the insulin receptor (InsR) to AKT and decreased glucose uptake.
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Previewsplay key roles in endocytosis and in facil-
itating a number of extracellular signal
transduction events, including insulin
signaling. Using a multitude of cellular
and animal model systems, the authors
show that miR-103/107 overexpression
or antagonism modulates Cav1 expres-
sion, with concomitant effects on insulin
receptor phosphorylation and down-
stream signaling to AKT (Figure 1B).
Cav1 KO mice were used to show that
miR-103/107 effects on insulin signaling
and glucose homeostasis in fat and liver
are lost in these animals. A caveat to these
studies is that knockout of Cav1 could
have pleiotropic effects on other caveo-
lae-dependent signaling pathways or
cholesterol/lipid metabolism that affects
animal homeostasis (Parton and Simons,
2007) and may independently modulate
insulin signaling/glucose metabolism.
These findings suggest that miRNA tar-
geting of Cav1 could function as a critical
rheostat for a cell’s responsiveness to
insulin, and dysregulation of miR-103/
107 may potentially contribute to obesity-
related metabolic abnormalities.
Importantly, a number of miRNAs have
been shown to coordinately regulate mul-
tiple components of pathways guiding150 Cell Metabolism 14, August 3, 2011 ª201animal development or physiology, and it
is tempting to speculate that miR-130/107
may also control the expression of addi-
tional genes involved inmodulating insulin
response and glucose/energy homeo-
stasis. Moreover, miR-130/107 could be
functionally linked with their pantothe-
nate kinase (PANK) host genes, which
are important for the production of coen-
zyme A (CoA), a key cofactor in numerous
metabolic processes (Wilfred et al., 2007).
Thus, miR-103/107 may integrate several
interwoven metabolic circuits governing
physiological homeostasis. Although un-
doubtedly complex, the miR-103/107
systemmay offer an avenue of therapeutic
approach for insulin resistance and, along
with other miRNAs, represent an exciting
advance of our understanding of meta-
bolic homeostasis in normal physiology
and human disease. Antisense-based
therapeutic targeting of miRNAs such as
miR-103/107may serve as a novel avenue
for the treatment of conditions associated
with metabolic syndrome.ACKNOWLEDGMENTS
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